StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report published on Friday morning. The brokerage issued a hold rating on the stock.
Brooklyn ImmunoTherapeutics Stock Performance
Brooklyn ImmunoTherapeutics stock opened at $1.66 on Friday. The stock has a 50-day simple moving average of $1.87 and a 200 day simple moving average of $1.98. The stock has a market capitalization of $97.36 million, a P/E ratio of -0.73 and a beta of 4.61. Brooklyn ImmunoTherapeutics has a 52 week low of $0.17 and a 52 week high of $10.10.
About Brooklyn ImmunoTherapeutics
See Also
- Five stocks we like better than Brooklyn ImmunoTherapeutics
- What is the Nikkei 225 index?
- From Tokyo to Wall Street: Japan’s Market Impact on U.S. Stocks
- Investing In Preferred Stock vs. Common Stock
- Arm Holdings: Does the 42% Drop Signal an AI Buying Opportunity?
- Find and Profitably Trade Stocks at 52-Week Lows
- Texas Roadhouse Stampedes On EPS Beat as Comp Sales Surge 9.3%
Receive News & Ratings for Brooklyn ImmunoTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brooklyn ImmunoTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
